September 20, 2013— The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
September 17, 2013 — In a significant milestone toward obtaining additional key regulatory approvals for the Synergy dru ...
September 9, 2013 — Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology ...
August 28, 2013 — According to Millennium Research Group (MRG), efforts to streamline the regulatory approval process in ... |
August 26, 2013 — Boston Scientific Corp. has completed enrollment in the SuperNOVA trial – a global, single arm ...
August 19, 2013 — Cook Medical is again shipping its Zilver PTX drug-eluting peripheral stent to medical centers in the ...
August 16, 2013 — Patient enrollment has been initiated in a post-market registry for the Combo Dual Therapy Stent to ...
August 5, 2013 — AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence ...
August 1, 2013 — InspireMD Inc. said the first patient has been enrolled in the Master II IDE clinical trial to evaluate ...
July 18, 2013 — Abbott announced that it has entered into an agreement to purchase IDEV Technologies, a privately held ...
July 12, 2013 — Micell Technologies Inc. received CE mark approval for its MiStent sirolimus-eluting absorbable polymer ...
July 1, 2013 — Primary end-point results from the BIOFLOW-II clinical study demonstrating the non-inferiority of the ...
June 24, 2013 — Final six and 12-month results of the DIRECT first-in-man clinical study were presented by study ...
June 13, 2013 — Tryton Medical Inc. announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton ...